Test Price
2,800 AED✅ Home Collection Available
C21orf2 Gene Cone-Rod Dystrophy Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين C21orf2 لضمور المخروط والعصا في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
UAE Trust & Executive Summary
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 accredited NGS processing (Cert: INT/EGQ/2509DA/3139), aligned with 2026 DHA clinical guidelines.
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection (DNA FTA card, whole blood, or extracted DNA) with ISO Certified Cold‑Chain Home Collection. VIP Mobile Phlebotomy available 8 AM‑11 PM.
- ✓ Clinical Guidance: Complimentary telephonic post‑test clinical guidance to interpret results in the context of your family history and ophthalmological findings.
- ✓ Insurance & Billing: Direct Billing Verification via WhatsApp at +971 54 548 8731.
يقدم مركزنا الطبي تحليلًا جينيًا متطورًا لجين C21orf2 للكشف عن ضمور المخروط والعصا، مع ضمان دقة تصل إلى 99.9% من خلال تقنيات حديثة معتمدة من هيئة الصحة بدبي. تتضمن الخدمة سحب عينات منزلية ونقلها وفق أعلى معايير الجودة. مدة النتائج 3 إلى 4 أسابيع. يتوفر دعم استشاري بعد الفحص لتوضيح النتائج.
Overview
The C21orf2 gene test identifies pathogenic variants causing cone‑rod dystrophy, a progressive inherited retinal disorder that affects central and peripheral vision. By sequencing the entire coding region of C21orf2 and associated retinal genes, this test offers a definitive molecular diagnosis, guiding prognosis and family planning (تحليل جيني يهدف إلى تأكيد تشخيص ضمور المخروط والعصا وتقديم المشورة الوراثية).
| Feature | Our Test (NGS Panel) | Single‑Gene Sanger Sequencing |
|---|---|---|
| Gene Coverage | Full C21orf2 gene + 30+ retinal dystrophy genes | Only C21orf2 coding regions |
| Detection Depth | >200× mean depth, >99.9% sensitivity | ~100× coverage, possible false negatives |
| Turnaround Time | 3 ‑ 4 weeks | 4 ‑ 6 weeks |
| Price | 2800 AED | Often 2500 ‑ 3000 AED (limited scope) |
| Regulatory Compliance | ISO 9001:2015, DHA FDL‑41/2024, CDS 2026 | Variable |
Physician Insight & Safety Protocol
“A positive C21orf2 result confirms the genetic cause of your cone‑rod dystrophy, but it must be interpreted alongside a comprehensive retinal examination and detailed family pedigree. Genetic information is permanent; our role is to ensure you fully understand what it means for your vision, your children, and your future care. We are committed to guiding you through each result with clarity and compassion.”
— Dr. PRABHAKAR REDDY, DHA License 61713011, Lead Clinical Consultant
⚠️ Medication Warning:
Do not discontinue any prescribed medication or vitamin supplement without consulting your treating ophthalmologist or physician. Your eye health management plan must remain unchanged until all test results are discussed.
Safety Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Bone marrow transplant recipients (allogeneic) due to potential chimerism that may invalidate genetic results. Patients with known large‑scale genomic rearrangements that interfere with NGS should discuss alternative methods with our genetic counselor.
- Immediate ER Red Flags: If you experience sudden vision loss, severe eye pain, flashes of light, or a curtain‑like shadow in your field of vision, seek emergency ophthalmic care immediately. This test is not a substitute for acute clinical evaluation.
- All samples are processed under the UAE Personal Data Protection Law (PDPL) and Federal Decree‑Law No. 41 of 2024, Article 87, ensuring full confidentiality and informed consent.
Patient FAQ & Clinical Guidance
1. What does the C21orf2 gene test detect, and why is it essential for cone‑rod dystrophy diagnosis?
It identifies pathogenic DNA mutations in the C21orf2 gene that cause cone‑rod dystrophy, providing a definitive molecular diagnosis that confirms the clinical suspicion and aids in predicting disease progression.
الكشف عن الطفرات الجينية المرضية في جين C21orf2 المسبب لضمور المخروط والعصا، مما يؤكد التشخيص سريريًا ويساعد في تحديد مسار تدهور البصر.
2. How is the sample collected, and can I use a painless FTA card at home?
A hospital‑grade home collection service collects a few drops of blood from a finger prick onto an FTA card, or a venous blood sample, all handled with cold‑chain integrity — it’s minimally invasive and requires no prior appointment except through WhatsApp.
يتم سحب العينة منزليًا بواسطة طاقم تمريضي معتمد؛ يمكن استخدام بطاقة FTA من وخز الإصبع أو دم وريدي، مع ضمان سلسلة تبريد مثالية.
3. Will my insurance cover this genetic, and how can I verify coverage?
Many UAE‑based insurers cover medically indicated genetic tests for inherited retinal diseases; our billing team performs direct verification within 2 hours when you send your Emirates ID and insurance card via WhatsApp to +971 54 548 8731.
معظم شركات التأمين تغطي هذا التحليل إذا كان هناك دواع طبية؛ يتحقق فريقنا من التغطية خلال ساعتين عبر إرسال الهوية وبطاقة التأمين على الواتساب.
عضو هيئة الصحة بدبي | DHA Licensed Facility 9834453
ISO 9001:2015 Certified (INT/EGQ/2509DA/3139) • CDS Law 2026 Compliant for Minors
امتثال صارم لقانون المرسوم بقانون اتحادي رقم 41 لسنة 2024 المادة 87
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians